Our team will be in Clemson, SC at the 2019 SEBSA Biosafety Symposium May 16–17. We’ll be sharing how our comprehensive review and oversite of clinical trials involving recombinant DNA, synthetic nucleic acid molecules, genetic engineering, and gene therapy research makes your research altogether better. Ask us how you can get local IBC submission support with our IBC-Ready™ program.
If you’re attending the symposium, be sure to catch the following presentation:
The U.S. Regulatory Environment Is Evolving to Accommodate a Coming Boom in Gene Therapy Research
Dan Eisenman, Director, Biosafety Services, Advarra